Jan 20, 2025 The Dermatology Digest: Maui Derm News: DecisionDx-SCC Improves Risk Stratification Among Patients With SCC Tumors on the Head or Neck When Combined With BWH Staging
Jan 6, 2025 Medical Device Network: Castle Biosciences Gains New York State Approval for Barrett's Oesophagus Test
Dec 27, 2024 Practical Dermatology: Castle Biosciences' Test Identifies AD Patients Likely to Achieve EASI90
Dec 12, 2024 The Dermatology Digest: Meta-analysis: Castle Biosciences’ DecisionDx-Melanoma Test Accurately Stratifies Patients based on Risk of Recurrence and Metastasis
Dec 1, 2024 The Dermatology Digest: Innovations in Personalized Medicine: Understanding and Utilizing DecisionDx-Melanoma
